• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

www.cigarettes-com.net 9/14/12


Department of Health and Human Services logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
 Center for Tobacco Products
9200 Corporate Boulevard
Rockville, MD 20850-3229

SEP 14, 2012

VIA Electronic Mail
To: sales@cigarettes-com.net
The Center for Tobacco Products of the Food and Drug Administration (FDA) recently reviewed your website, http://www.cigarettes-com.net, and determined that the cigarette products listed there are offered for sale to U.S. customers. Under section 201(rr) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. § 321(rr)), as amended by the Family Smoking Prevention and Tobacco Control Act, these products are tobacco products because they are made or derived from tobacco and intended for human consumption. Certain tobacco products, including cigarettes, are subject to FDA jurisdiction under section 901(b) of the FD&C Act (21 U.S.C. § 387a(b)).
FDA has determined that several of your products are adulterated under section 902(8) of the FD&C Act (21 U.S.C. § 387b(8)) because you promote them as modified risk tobacco products without an FDA order in effect that permits such promotion. You can find the FD&C Act through links on FDA’s homepage at http://www.fda.gov.
You describe products that you offer for sale on your website, http:///www.cigarettes-com.net, as being light, extra light, super light, and premium light by referring to them as such in product advertising and adding the qualifiers “Lights,” “Extra Lights,” “Super Lights,” “Premium Lights” to the product names. Specifically, our review of your website revealed that you offer for sale the following cigarettes: ATIS Noble (“ATIS Super Lights (Noble)”); BOND Street Original Selection (“BOND Lights”), BOND Street Fine Selection (“BOND Super Lights”); CAMEL Subtle Flavour (“CAMEL Lights”), CAMEL Refined Flavour (“CAMEL Super Lights”); Chesterfield Classic Blue (“CHESTERFIELD Blue (Lights)”), Chesterfield Bronze (“CHESTERFIELD Bronze (Super Lights)”); Classic Blue (“Classic Lights”), Classic Silver (“Classic Super Lights”); Gauloises Blondes (“Gauloises Yellow (Super Lights)”); Karelia Slims Menthol (“Karelia Menthol Lights”); Kent Blue Futura (Premium Lights 8), Kent Silver Neo (Super Lights 4); L&M Blue Label (“L&M Blue (Lights)”), L&M Silver Label (“L&M Silver (Super Lights)”); Lucky Strike Original Silver (“Lucky Strike Silver (Lights)”); Marlboro Gold Original (“Marlboro Gold (Lights)”); Monte Carlo Balanced Blue (“Monte Carlo Blue (Lights)”), Montel Carlo Subtle Silver (“Monte Carlo Silver (Super Lights)”); Parliament Aqua Blue (Lights), Parliament Silver Blue (Extra Lights); President Special Stars (“President Lights”); RED & WHITE Special (“Red&White Lights (Special)”), RED & WHITE Fine (“Red&White Super Lights (Fine)”); Virginia S. (“Virginia Slims SuperSlims Lights (4 Cartons)”); and, Winston Balanced Blue (“Winston Blue (Lights)”), Winston Subtle Silver (“Winston Silver (Super Lights)”).
A tobacco product with a label, labeling, or advertising that uses the descriptor “light,” “mild,” or “low,” or a similar descriptor, is a “modified risk tobacco product” under section 911(b)(2)(A)(ii) of the FD&C Act (21 U.S.C. § 387k(b)(2)(A)(ii)). Under section 911(a) of the FD&C Act (21 U.S.C. § 387k(a)), no person may introduce or deliver for introduction into interstate commerce any modified risk tobacco product without an FDA order in effect under section 911(g) of the FD&C Act (21 U.S.C. § 387k(g)). A product that is in violation of section 911(a) of the FD&C Act (21 U.S.C. § 387k(a)) is adulterated under section 902(8) of the FD&C Act (21 U.S.C. § 387b(8)). Because your website uses the descriptor “Light,” or similar descriptors for the above-listed products, the products are modified risk tobacco products. Because these products are offered for sale to U.S. customers without an appropriate FDA order in effect under section 911(g) of the FD&C Act (21 U.S.C. § 387k(g)), these products are adulterated under section 902(8) of the FD&C Act (21 U.S.C. § 387b(8)).
You should immediately correct the violations stated above and take any necessary actions to bring your tobacco products into compliance with the FD&C Act. The violations discussed in this letter do not necessarily constitute an exhaustive list, and it is your responsibility to ensure that your tobacco products on this website, or any other websites you own, operate, and/or control, comply with the applicable provisions of the FD&C Act. Failure to ensure full compliance with the FD&C Act may result in FDA initiating further action without notice, including, but not limited to, civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, and/or injunction. Please note that adulterated and misbranded tobacco products offered for importation into the United States are subject to detention and refusal of admission.
Please submit a written response to this letter within 15 working days from the date of receipt describing your corrective actions, including the dates on which you discontinued the violative promotion, advertising, sale, and/or distribution of these tobacco products. 
Please note your reference number, RW1200034, in your response and direct your response to the following address:
PAL-WL Response, Office of Compliance and Enforcement
FDA Center for Tobacco Products
9200 Corporate Boulevard
c/o Document Control Center
Rockville, Maryland 20850 
If you have any questions about the content of this letter, please contact Ele Ibarra-Pratt at (301) 796-9235 or via email at Elenita.IbarraPratt@fda.hhs.gov.     
Ann Simoneau, J.D.
Office of Compliance and Enforcement
Center for Tobacco Products
VIA UPS,Electronic Mail
DomainPeople, Inc.
Bentall 5, Suite 200
550 Burrard Street
Vancouver, BC
Canada V6C 2B5
Andrey Almazov
Vladimir Vaynshteyn